Bristol-Myers Squibb's Options Frenzy: What You Need to Know
Bristol-Myers Squibb's Options Frenzy: What You Need to Know
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $41.0 and $55.0 for Bristol-Myers Squibb, spanning the last three months.Deep-pocketed investors have adopted a bullish approach towards Bristol-Myers Squibb (NYSE:BMY), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BMY usually suggests something big is about to happen.
对于Bristol-Myers Squibb (NYSE:BMY)，深口袋的投资者采取了看好的态度，这是市场参与者不应忽视的事情。本站对Benzinga的公开期权记录进行了跟踪，今天揭示了这一重要的举动。这些投资者的身份尚不明确，但BMY的如此大规模的交易通常意味着有大事发生。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Bristol-Myers Squibb. This level of activity is out of the ordinary.
我们通过今天的观察获得了这些信息，当Benzinga的期权扫描仪突出了9个施贵宝的非凡期权活动时。这种活动水平是不寻常的。
The general mood among these heavyweight investors is divided, with 44% leaning bullish and 22% bearish. Among these notable options, 4 are puts, totaling $138,637, and 5 are calls, amounting to $207,540.
这些大户投资者的总体情绪分裂，有44%看好，22%看淡。在这些显著的期权中，有4个看跌，总额达到$138,637，有5个看涨，总额达到$207,540。
What's The Price Target?
目标价是多少？
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $41.0 and $55.0 for Bristol-Myers Squibb, spanning the last three months.
在评估交易量和未平仓合约后，很明显主要的市场推动者正专注于施贵宝的价格区间，在过去三个月内介于$41.0和$55.0之间。
Analyzing Volume & Open Interest
分析成交量和未平仓合约
In today's trading context, the average open interest for options of Bristol-Myers Squibb stands at 3613.11, with a total volume reaching 1,952.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Bristol-Myers Squibb, situated within the strike price corridor from $41.0 to $55.0, throughout the last 30 days.
在今天的交易背景下，施贵宝的期权平均未平仓合约为3613.11，总成交量达到1,952.00。 附带的图表描绘了过去30天内施贵宝高价交易的看涨和看跌期权成交量和未平仓合约的进展，这些交易位于$41.0到$55.0的行权价格走廊内。
Bristol-Myers Squibb 30-Day Option Volume & Interest Snapshot
施贵宝30天期权成交量和未平仓合约快照
Significant Options Trades Detected:
检测到重大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | CALL | SWEEP | BULLISH | 01/17/25 | $5.6 | $5.5 | $5.6 | $45.00 | $56.5K | 7.7K | 104 |
| BMY | CALL | TRADE | BULLISH | 01/16/26 | $9.25 | $9.2 | $9.25 | $43.00 | $46.2K | 6.8K | 60 |
| BMY | CALL | SWEEP | BULLISH | 03/21/25 | $9.25 | $9.1 | $9.2 | $41.00 | $45.9K | 1 | 51 |
| BMY | PUT | TRADE | NEUTRAL | 01/16/26 | $7.75 | $7.65 | $7.7 | $52.50 | $38.5K | 689 | 50 |
| BMY | PUT | SWEEP | BEARISH | 01/17/25 | $1.75 | $1.69 | $1.72 | $45.00 | $38.0K | 7.7K | 265 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | 看涨 | SWEEP | 看好 | 01/17/25 | $5.6 | $5.5 | $5.6 | $45.00 | $56.5千 | 7.7K | 104 |
| BMY | 看涨 | 交易 | 看好 | 01/16/26 | 9.25美元 | $9.2 | 9.25美元 | 据TipRanks.com称，Carcache是一名5星级分析师，平均回报率为19.0％，成功率为68.5％，涵盖了金融板块，重点关注Bread Financial Holdings、第一资本信贷和Ryan Specialty Group等股票。 | $46.2千 | 6.8K | 60 |
| BMY | 看涨 | SWEEP | 看好 | 03/21/25 | 9.25美元 | $9.1 | $9.2 | 41.00美元 | $45.9K | 1 | 51 |
| BMY | 看跌 | 交易 | 中立 | 01/16/26 | $7.75 | $7.65 | $7.7 | $52.50 | $38.5K | 689 | 50 |
| BMY | 看跌 | SWEEP | 看淡 | 01/17/25 | $1.75 | $1.69 | 1.72美元 | $45.00 | $38.0K | 7.7K | 265 |
About Bristol-Myers Squibb
关于施贵宝
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
施贵宝发现、开发和营销用于心血管疾病、癌症和免疫障碍等多种治疗领域的药品。施贵宝的重点关注点是免疫肿瘤学，该公司是药品研发领域的领导者。施贵宝近70%的总销售额来自美国，显示了该公司对美国市场的更高依赖性，高于其大多数同行。
After a thorough review of the options trading surrounding Bristol-Myers Squibb, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
在对Bristol-Myers Squibb周围的期权交易进行全面审查后，我们进一步细致地研究了该公司。这将包括对其目前的市场地位和表现的评估。
Current Position of Bristol-Myers Squibb
施贵宝的当前仓位
- With a trading volume of 4,688,294, the price of BMY is down by -1.48%, reaching $48.26.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 64 days from now.
- 当前RSI值表明该股票可能接近超买状态。
- 下一份盈利报告将在64天后发布。
What The Experts Say On Bristol-Myers Squibb
专家对施贵宝的看法
3 market experts have recently issued ratings for this stock, with a consensus target price of $46.333333333333336.
- Consistent in their evaluation, an analyst from TD Cowen keeps a Hold rating on Bristol-Myers Squibb with a target price of $53.
- An analyst from Deutsche Bank persists with their Hold rating on Bristol-Myers Squibb, maintaining a target price of $45.
- An analyst from Barclays downgraded its action to Underweight with a price target of $41.
- 德意志银行的分析师坚持对Bristol-Myers Squibb的持有评级，维持目标价为45.0美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bristol-Myers Squibb options trades with real-time alerts from Benzinga Pro.
期权交易具有更高的风险和潜在回报。精明的交易者通过不断学习、调整策略、监控多个因子以及密切关注市场走势来管理这些风险。通过Benzinga Pro的实时警报，及时了解最新的施贵宝期权交易。
